How I treat refractory thrombotic thrombocytopenic purpura.

Blood
Farzana A Sayani, Charles S Abrams

Abstract

Acquired thrombotic thrombocytopenic purpura (TTP) is characterized by thrombocytopenia and microangiopathic hemolytic anemia (MAHA) without an obvious cause, and may include fever, mild renal failure, and neurologic deficits. It is characterized by a deficiency of the von Willebrand factor (VWF) cleaving enzyme, ADAMTS13 (a disintegrin and metalloproteinase, with a thrombospondin type 1 motif, member 13), resulting in formation of microthrombi in the high sheer environment of the microvasculature. This causes microvascular occlusion, MAHA, and organ ischemia. Diagnosis is based on the presence of clinical symptoms, laboratory aberrations consistent with MAHA, decreased ADAMTS13 activity, and possibly presence of anti-ADAMTS13 autoantibodies. Upfront treatment of acute TTP includes plasma exchange and corticosteroids. A significant number of patients are refractory to this treatment and will require further interventions. There are limited data and consensus on the management of the refractory TTP patient. Management involves simultaneously ruling out other causes of thrombocytopenia and MAHA, while also considering other treatments. In this article, we describe our management of the patient with refractory TTP, and discuss use...Continue Reading

References

Sep 1, 1992·American Journal of Hematology·M ToyoshigeT Kaneko
Jan 1, 1991·Journal of Clinical Apheresis·A W RobertsS J Fleming
Apr 1, 1991·The Western Journal of Medicine·K V ShepardR M Bukowski
Apr 1, 1987·American Journal of Hematology·J B BlitzerH Lamberson
Jun 15, 1993·Annals of Internal Medicine·H KierdorfB Heintz
Jan 1, 1996·American Journal of Hematology·W R Bachman, J K Brennan
Jun 1, 1997·British Journal of Haematology·K SpiekermannW Hiddemann
Jan 10, 1998·American Journal of Hematology·D PasqualeG Chikkappa
Aug 1, 1997·Australian and New Zealand Journal of Medicine·M S Hertzberg, J Koutts
May 20, 1998·Journal of Clinical Apheresis·C MazzeiD Goldfinger
Nov 26, 1998·The New England Journal of Medicine·H M Tsai, E C Lian
Sep 28, 2002·American Journal of Hematology·Jens ChemnitzDietmar Söhngen
Jan 17, 2003·Annals of Internal Medicine·Xinglong ZhengMorey A Blinder
Jul 23, 2003·Journal of Clinical Apheresis·Nicole A AquiFrank J Strobl
Jan 17, 2004·Seminars in Hematology·Barbara Plaimauer, Friedrich Scheiflinger
Aug 6, 2004·International Journal of Hematology·Gideon Y SteinMoshe Mittelman
Sep 25, 2004·American Journal of Hematology·Afaq AhmadGeraldine P Schechter
Aug 24, 2005·British Journal of Haematology·M C Kappers-KlunneA Brand
Dec 24, 2005·British Journal of Haematology·P CoppoUNKNOWN Réseau d'Etude des Microangiopathies Thrombotiques de l'Adulte
Jan 25, 2006·Autoimmunity Reviews·Giovanni Franchin, Betty Diamond
Aug 21, 2008·Journal of Clinical Apheresis·Sushama JastiBernard Poiesz
Mar 12, 2009·Cardiovascular & Hematological Disorders Drug Targets·Paul Coppo, Agnès Veyradier
Jun 13, 2009·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Kenar D JhaveriBruce Gordon
Aug 12, 2009·Current Opinion in Organ Transplantation·Jason J EverlyE Steve Woodle

❮ Previous
Next ❯

Citations

Feb 11, 2016·The New England Journal of Medicine·Agnès Veyradier
Aug 8, 2015·Journal of Thrombosis and Thrombolysis·Amihai RottenstreichYosef Kalish
Jun 23, 2016·The New England Journal of Medicine·Flora Peyvandi, Filip Callewaert
Jul 14, 2016·Medizinische Klinik, Intensivmedizin und Notfallmedizin·M Guthoff, N Heyne
Dec 8, 2015·Hematology·Paul CoppoUNKNOWN French Reference Center for Thrombotic Microangiopathies
Apr 19, 2017·Blood·Bérangère S JolyAgnès Veyradier
Jan 25, 2017·Intensive Care Medicine·Bérangère S JolyAgnès Veyradier
Jun 28, 2017·Journal of Clinical Apheresis·Ryan JajoskyNatasha Savage
Feb 15, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie R BrahmerUNKNOWN National Comprehensive Cancer Network
May 10, 2018·Scottish Medical Journal·Sinan DemircioğluCengiz Demir
Jun 26, 2018·Lab on a Chip·Keith H K WongMehmet Toner
Sep 13, 2018·Transfusion·William E PlautzMatthew D Neal
Oct 16, 2018·Journal of Clinical Apheresis·Emmanuel Bugarin-EstradaDavid Gómez-Almaguer
Sep 12, 2018·Blood·Matthieu JestinUNKNOWN French Thrombotic Microangiopathies Reference Center
Apr 13, 2019·Expert Review of Clinical Pharmacology·Maria Laura Sargentini-MaierHilde De Winter
Jul 3, 2018·American Journal of Therapeutics·Soumya ThummaJoseph Mattana
Oct 8, 2019·Intensive Care Medicine·Elie AzoulayUNKNOWN Nine-i Investigators
Apr 20, 2020·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Rui-Xue SunJing Yang
Jul 2, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Justin H ReidBernard L Marini
Jun 27, 2020·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Alyssa L HollifieldDonald C Moore
Sep 3, 2020·Expert Review of Hematology·Inés Gómez-SeguíJavier de la Rubia
Apr 4, 2017·Case Reports in Hematology·Manu R PandeyEvelena P Ontiveros
Jun 18, 2017·Frontiers in Immunology·Ralf J LudwigFalk Nimmerjahn
Dec 12, 2018·Journal of Clinical Apheresis·Léanne SwartJohnny N Mahlangu
Jul 28, 2017·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Damien G NooneChristoph Licht
Jun 22, 2017·Mediators of Inflammation·Felice GragnanoPaolo Calabrò
Apr 4, 2020·Expert Review of Hematology·Andrés Gómez-De LeónDavid Gómez-Almaguer
Jun 24, 2017·The Journal of International Medical Research·Haifei ChenLongmei Qing
Dec 19, 2018·Thrombosis Journal·Susan LouwElizabeth Sarah Mayne

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.